BioSpace News Archive

Biotech Bay

Gilead Presents New Data in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2019

New Proof-of-Concept Data for Combination of Investigational FXR Agonist Cilofexor and ACC Inhibitor Firsocostat in NASH

April 11, 2019
·
6 min read
Biotech Beach

ResMed Introduces AirFit P30i, Its First Top-of-Head-Connected Nasal Pillows CPAP Mask

Now offers “tube-up” design options for nasal and nasal pillows mask wearers, providing even more flexibility and choice to help users sleep better in any position

April 11, 2019
·
3 min read
Deals

Oncopeptides AB: Updated Financial Calendar

Oncopeptides AB announced that it has updated its financial calendar, the interim report for Q2 2019 have been moved to 28 August.

April 11, 2019
·
1 min read
Deals

West to Host First-Quarter 2019 Conference Call

West Pharmaceutical Services, Inc. announced that it will release first-quarter 2019 financial results before the market opens on Thursday, April 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

April 11, 2019
·
2 min read
BioForest

Martis Capital Closes Oversubscribed Fund III at $545 Million

Martis Capital Management, LLC, the healthcare-focused private equity firm, has closed its third fund, Martis Partners III, LP with $545 million in aggregate capital commitments.

April 11, 2019
·
1 min read
Business

Mallinckrodt and Washington University St. Louis Select First Collaborative Research Endeavor

Discovery program aimed at identifying potential new drugs targeting chronic itch, a serious condition spanning multiple disorders

April 11, 2019
·
5 min read
Business

Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase

Opsens Inc. reported its results for the second quarter of 2019.

April 11, 2019
·
3 min read
Drug Development

Concert Pharmaceuticals to Present CTP-543 Phase 2 Interim Data in Alopecia Areata at 2019 World Congress for Hair Research Annual Meeting

Concert Pharmaceuticals, Inc. announced that interim clinical data from its CTP-543 Phase 2 trial in alopecia areata will be presented in a poster presentation and a sponsored lecture at the 11th Annual World Congress for Hair Research being held April 24-27, 2019 in Sitges, Barcelona.

April 11, 2019
·
4 min read
Policy

Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices

Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced that it has obtained ISO 13485:2016 certification.

April 11, 2019
·
2 min read
Biotech Beach

Introducing EQUELLE®: A New Non-Hormonal Supplement for Menopause Symptom Relief†

EQUELLE, a new non-prescription, non-hormonali supplement clinically shown to alleviate the frequency of hot flashes and muscle aches associated with menopause†, has launched.

April 11, 2019
·
3 min read